Bone Scan Index: a strong predictor of outcome in metastatic hormone naive prostate cancer patients

被引：0
|
作者：
Rasmussen, J. [1 ]
Poulsen, M. [2 ]
Johansen, A. [1 ]
Lund, L. [2 ]
Hoilund-Carlsen, P. [1 ]
Gerke, O. [1 ,3 ]
Edenbrandt, L. [4 ]
机构：
[1] Odense Univ Hosp, Dept Nucl Med, DK-5000 Odense, Denmark
[2] Odense Univ Hosp, Dept Urol, DK-5000 Odense, Denmark
[3] Univ Southern Denmark, Dept Econ & Business, Odense, Denmark
[4] Lund Univ, Nucl Med Unit, Skane Univ Hosp, Malmo, Sweden
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2013年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S470 / S470
页数：1
相关论文
共 50 条
  • [41] PROSTATE CANCER Bone Scan Index made easy, at last
    Tombal, Bertrand
    NATURE REVIEWS UROLOGY, 2012, 9 (05) : 245 - 246
  • [42] Bone scan index as a new imaging biomarker in response assessment of prostate cancer patients with bone metastasis
    Park, Sonya
    Srinivas, Sandy
    Mittra, Erik
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [43] Bone Scan Index Is an Independent Predictor of Time to Castration-resistant Prostate Cancer in Newly Diagnosed Prostate Cancer: A Prospective Study REPLY
    Zacho, Helle D.
    Petersen, Lars J.
    Mortensen, Jesper C.
    Bertelsen, Henrik
    Boldsen, Soren K.
    Barsi, Tamas
    Petersen, Lars J.
    UROLOGY, 2017, 108 : 141 - 141
  • [44] Predictive value of bone scan index using computer-aided diagnosis system for bone scans in patients receiving first-line hormone therapy for metastatic hormone-sensitive prostate cancer.
    Miyoshi, Yasuhide
    Yasui, Masato
    Yoneyama, Shuko
    Uemura, Koichi
    Kawahara, Takashi
    Hattori, Yusuke
    Teranishi, Jun-ichi
    Ohta, Jun-ichi
    Yokomizo, Yumiko
    Taguri, Masataka
    Uemura, Hiroji
    Yao, Masahiro
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [45] Pre-treatment Bone Scan Index as an Outcome Measure Predicting for Survival in Patients with Castration-Refractory Prostate Cancer
    Edenbrandt, L.
    Hoglund, P.
    Leek, H.
    Ohlsson, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S270 - S270
  • [46] Change in bone alkaline phosphatase as an outcome predictor in men with hormone-refractory prostate cancer metastasized to bone.
    Allen, AR
    Saad, F
    Hulting, SM
    Isaacson, JD
    Sleep, DJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 420S - 420S
  • [47] Survival outcome following hormone manipulation of metastatic prostate cancer
    Kotwal, S.
    Dhulipala, R.
    Whelan, P.
    BJU INTERNATIONAL, 2008, 101 : 8 - 8
  • [48] In Hormone-Naive Metastatic Prostate Cancer, Should All Patients Now Receive Docetaxel? No, Not Yet
    Armstrong, Andrew J.
    ONCOLOGY-NEW YORK, 2014, 28 (10): : 881 - +
  • [49] A Phase II Study of Cabozantinib and Androgen Ablation in Patients with Hormone-Naive Metastatic Prostate Cancer
    Corn, Paul G.
    Zhang, Miao
    Nogueras-Gonzalez, Graciela M.
    Xiao, Lianchun
    Zurita, Amado J.
    Subudhi, Sumit K.
    Tu, Shi-Ming
    Aparicio, Ana M.
    Coarfa, Cristian
    Rajapakshe, Kimal
    Huang, Shixia
    Navone, Nora M.
    Lin, Sue-Hwa
    Wang, Guocan
    Ramachandran, Sumankalai
    Titus, Mark A.
    Panaretakis, Theocharis
    Gallick, Gary E.
    Efstathiou, Eleni
    Troncoso, Patricia
    Logothetis, Christopher
    CLINICAL CANCER RESEARCH, 2020, 26 (05) : 990 - 999
  • [50] Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamide
    Aseem Anand
    Michael J. Morris
    Steven M. Larson
    David Minarik
    Andreas Josefsson
    John T. Helgstrand
    Peter S. Oturai
    Lars Edenbrandt
    Martin Andreas Røder
    Anders Bjartell
    EJNMMI Research, 6
12345